FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006018047> ?p ?o ?g. }

• W2006018047 endingPage "327" @default.
• W2006018047 startingPage "319" @default.
• W2006018047 abstract "Background and objective: Due to drug-related problems (DRPs) that cause both unnecessary suffering and huge costs to society, many patients do not receive the intended beneficial effects of their treatment. Pharmacy practitioners have a key responsibility to respond to these problems, but more knowledge about the expected outcomes of their interventions is needed. The objective of the study was to assess the clinical and economic outcomes of community pharmacy interventions in patient DRPs. Methods: Drug-related problems in 13 different patient groups were identified and classified, according to the Westerlund System, by pharmacy practitioners from 89 Swedish pharmacies in 2006. The cases were documented in the pharmacy software and transferred to the national DRP database. An assessment model was developed and applied by the researchers (a pharmacist and a physician). This assessment was used to conduct a retrospective review by analysing the DRP and intervention documentation, in particular case descriptions from free text fields. Expected clinical patient outcomes of pharmacy interventions were judged in terms of improved therapeutic effects and prevented or relieved adverse drug reactions (ADRs). The review also assessed the expected patient outcomes with regard to initiated or avoided primary care contacts or avoided hospitalisations. The resulting hypothetically avoided direct societal costs and the estimated pharmacy personnel costs were calculated for the study and extrapolated to the Swedish nationwide level on an annual basis, to demonstrate the potential of national cost savings by pharmacy DRP-interventions. Results and discussion: In 358 cases (68%), the pharmacy interventions were judged to have produced an improved therapeutic effect in the patient, and in 172 cases (32%) to have prevented or relieved ADRs. Primary care contacts were initiated for 151 patients (29%), and pharmacy interventions were assessed to have saved 68 (13%) primary care contacts and 16 (3%) future hospitalisations. The potential societal cost savings extrapolated to Sweden at the national level were estimated at € 358 million. This is 37 times the expected pharmacy personnel costs for identifying and responding to the DRPs. Conclusion: Our study demonstrates that community pharmacy interventions in patient DRPs are most likely to lead to favourable clinical and economic outcomes. The convincing cost-benefit ratio should be presented to health care politicians and decision makers to encourage appropriate remuneration for these services." @default.
• W2006018047 created "2016-06-24" @default.
• W2006018047 creator A5015349927 @default.
• W2006018047 creator A5082244057 @default.
• W2006018047 date "2009-06-01" @default.
• W2006018047 modified "2023-10-07" @default.
• W2006018047 title "Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems" @default.
• W2006018047 cites W1969879564 @default.
• W2006018047 cites W1988304729 @default.
• W2006018047 cites W2012575785 @default.
• W2006018047 cites W2019876752 @default.
• W2006018047 cites W2020607052 @default.
• W2006018047 cites W2022909531 @default.
• W2006018047 cites W2023112383 @default.
• W2006018047 cites W2031853633 @default.
• W2006018047 cites W2047871802 @default.
• W2006018047 cites W2051410360 @default.
• W2006018047 cites W2057748072 @default.
• W2006018047 cites W2098480861 @default.
• W2006018047 cites W2101658931 @default.
• W2006018047 cites W2103789057 @default.
• W2006018047 cites W2105814725 @default.
• W2006018047 cites W2108300523 @default.
• W2006018047 cites W2113761181 @default.
• W2006018047 cites W2116147633 @default.
• W2006018047 cites W2130736933 @default.
• W2006018047 cites W2138653626 @default.
• W2006018047 cites W2144276274 @default.
• W2006018047 cites W2149863648 @default.
• W2006018047 cites W2163590219 @default.
• W2006018047 cites W4292198115 @default.
• W2006018047 doi "https://doi.org/10.1111/j.1365-2710.2008.01017.x" @default.
• W2006018047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19646078" @default.
• W2006018047 hasPublicationYear "2009" @default.
• W2006018047 type Work @default.
• W2006018047 sameAs 2006018047 @default.
• W2006018047 citedByCount "78" @default.
• W2006018047 countsByYear W20060180472012 @default.
• W2006018047 countsByYear W20060180472013 @default.
• W2006018047 countsByYear W20060180472014 @default.
• W2006018047 countsByYear W20060180472015 @default.
• W2006018047 countsByYear W20060180472016 @default.
• W2006018047 countsByYear W20060180472017 @default.
• W2006018047 countsByYear W20060180472018 @default.
• W2006018047 countsByYear W20060180472019 @default.
• W2006018047 countsByYear W20060180472020 @default.
• W2006018047 countsByYear W20060180472021 @default.
• W2006018047 countsByYear W20060180472022 @default.
• W2006018047 countsByYear W20060180472023 @default.
• W2006018047 crossrefType "journal-article" @default.
• W2006018047 hasAuthorship W2006018047A5015349927 @default.
• W2006018047 hasAuthorship W2006018047A5082244057 @default.
• W2006018047 hasConcept C10446079 @default.
• W2006018047 hasConcept C104863432 @default.
• W2006018047 hasConcept C129930760 @default.
• W2006018047 hasConcept C159110408 @default.
• W2006018047 hasConcept C17744445 @default.
• W2006018047 hasConcept C199360897 @default.
• W2006018047 hasConcept C199539241 @default.
• W2006018047 hasConcept C27415008 @default.
• W2006018047 hasConcept C2779457091 @default.
• W2006018047 hasConcept C2779473830 @default.
• W2006018047 hasConcept C2780665704 @default.
• W2006018047 hasConcept C41008148 @default.
• W2006018047 hasConcept C512399662 @default.
• W2006018047 hasConcept C56666940 @default.
• W2006018047 hasConcept C71924100 @default.
• W2006018047 hasConceptScore W2006018047C10446079 @default.
• W2006018047 hasConceptScore W2006018047C104863432 @default.
• W2006018047 hasConceptScore W2006018047C129930760 @default.
• W2006018047 hasConceptScore W2006018047C159110408 @default.
• W2006018047 hasConceptScore W2006018047C17744445 @default.
• W2006018047 hasConceptScore W2006018047C199360897 @default.
• W2006018047 hasConceptScore W2006018047C199539241 @default.
• W2006018047 hasConceptScore W2006018047C27415008 @default.
• W2006018047 hasConceptScore W2006018047C2779457091 @default.
• W2006018047 hasConceptScore W2006018047C2779473830 @default.
• W2006018047 hasConceptScore W2006018047C2780665704 @default.
• W2006018047 hasConceptScore W2006018047C41008148 @default.
• W2006018047 hasConceptScore W2006018047C512399662 @default.
• W2006018047 hasConceptScore W2006018047C56666940 @default.
• W2006018047 hasConceptScore W2006018047C71924100 @default.
• W2006018047 hasIssue "3" @default.
• W2006018047 hasLocation W20060180471 @default.
• W2006018047 hasLocation W20060180472 @default.
• W2006018047 hasOpenAccess W2006018047 @default.
• W2006018047 hasPrimaryLocation W20060180471 @default.
• W2006018047 hasRelatedWork W2149214354 @default.
• W2006018047 hasRelatedWork W2336522585 @default.
• W2006018047 hasRelatedWork W2355255235 @default.
• W2006018047 hasRelatedWork W2369609386 @default.
• W2006018047 hasRelatedWork W2386240052 @default.
• W2006018047 hasRelatedWork W2387285409 @default.
• W2006018047 hasRelatedWork W2766518491 @default.
• W2006018047 hasRelatedWork W2883564924 @default.
• W2006018047 hasRelatedWork W2982180430 @default.
• W2006018047 hasRelatedWork W3112496438 @default.
• W2006018047 hasVolume "34" @default.

• next